- Home
- LOCL vs BOLD Comparison
LOCL vs BOLD Comparison
Compare LOCL & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCL
- BOLD
- Stock Information
- Founded
- LOCL 2021
- BOLD 2018
- Country
- LOCL United States
- BOLD United States
- Employees
- LOCL N/A
- BOLD N/A
- Industry
- LOCL Farming/Seeds/Milling
- BOLD
- Sector
- LOCL Consumer Staples
- BOLD
- Exchange
- LOCL Nasdaq
- BOLD Nasdaq
- Market Cap
- LOCL 35.8M
- BOLD 30.3M
- IPO Year
- LOCL N/A
- BOLD 2024
- Fundamental
- Price
- LOCL $2.03
- BOLD $1.13
- Analyst Decision
- LOCL
- BOLD Buy
- Analyst Count
- LOCL 0
- BOLD 3
- Target Price
- LOCL N/A
- BOLD $4.00
- AVG Volume (30 Days)
- LOCL 8.9K
- BOLD 79.0K
- Earning Date
- LOCL 05-14-2025
- BOLD 05-09-2025
- Dividend Yield
- LOCL N/A
- BOLD N/A
- EPS Growth
- LOCL N/A
- BOLD N/A
- EPS
- LOCL N/A
- BOLD N/A
- Revenue
- LOCL $41,360,000.00
- BOLD N/A
- Revenue This Year
- LOCL $62.21
- BOLD N/A
- Revenue Next Year
- LOCL $67.43
- BOLD N/A
- P/E Ratio
- LOCL N/A
- BOLD N/A
- Revenue Growth
- LOCL 41.44
- BOLD N/A
- 52 Week Low
- LOCL $1.18
- BOLD $1.06
- 52 Week High
- LOCL $5.75
- BOLD $10.13
- Technical
- Relative Strength Index (RSI)
- LOCL 38.83
- BOLD N/A
- Support Level
- LOCL $2.00
- BOLD N/A
- Resistance Level
- LOCL $2.20
- BOLD N/A
- Average True Range (ATR)
- LOCL 0.19
- BOLD 0.00
- MACD
- LOCL -0.01
- BOLD 0.00
- Stochastic Oscillator
- LOCL 17.81
- BOLD 0.00
About LOCL Local Bounti Corporation
Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.